drugset / Trial / NCT03559010

A Study of Oral Contraception Under Simulated OTC Conditions

NCT03559010

Phase 3 Terminated 189 enrolled HRA Pharma
NaSingle-groupOpen-labelOther

Summary

This study is designed to assess whether consumers select and use norgestrel 0.075 mg, a progestin only pill for contraception, in a manner consistent with the OTC package directions in an Over-the-Counter (OTC)-like setting.

Timeline

Start
2018-04-27
Primary completion
2018-09-09
Completion
2018-11-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Norgestrel Unknown 0.075 mg Oral

Indications

No indication recorded.